152 related articles for article (PubMed ID: 37325343)
1. Renal C4d is a potential biomarker of disease activity and severity in pediatric lupus nephritis patients.
Wang X; Fu S; Yu J; Tang D; Wu H; Xu Z
Front Pediatr; 2023; 11():1193917. PubMed ID: 37325343
[TBL] [Abstract][Full Text] [Related]
2. Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.
Li SJ; Liu ZH; Zen CH; Wang QW; Wang Y; Li LS
Lupus; 2007; 16(11):875-80. PubMed ID: 17971360
[TBL] [Abstract][Full Text] [Related]
3. Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients.
Martin M; Trattner R; Nilsson SC; Björk A; Zickert A; Blom AM; Gunnarsson I
Front Immunol; 2020; 11():582737. PubMed ID: 33133102
[TBL] [Abstract][Full Text] [Related]
4. Complement C4d as a biomarker for systemic lupus erythematosus and lupus nephritis.
Qin S; Wang X; Wang J; Wu H
Lupus; 2024 Feb; 33(2):111-120. PubMed ID: 38227433
[No Abstract] [Full Text] [Related]
5. Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.
Kim MK; Maeng YI; Lee SJ; Lee IH; Bae J; Kang YN; Park BT; Park KK
Int J Clin Exp Pathol; 2013; 6(10):2157-67. PubMed ID: 24133594
[TBL] [Abstract][Full Text] [Related]
6. The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients.
Ding Y; Yu X; Wu L; Tan Y; Qu Z; Yu F
Front Immunol; 2021; 12():654652. PubMed ID: 34276649
[TBL] [Abstract][Full Text] [Related]
7. Tubular basement membrane immune complex deposition is associated with activity and progression of lupus nephritis: a large multicenter Chinese study.
Wang H; Xu J; Zhang X; Ren YL; Cheng M; Guo ZL; Zhang JC; Cheng H; Xing GL; Wang SX; Yu F; Zhao MH
Lupus; 2018 Apr; 27(4):545-555. PubMed ID: 28954590
[TBL] [Abstract][Full Text] [Related]
8. Glomerular c4d staining can be an indicator of disease activity in lupus nephritis.
Sahin OZ; Gurses S; Taslı F; Yavas H; Ersoy R; Uzum A; Cirit M
Ren Fail; 2013; 35(2):222-5. PubMed ID: 23176021
[TBL] [Abstract][Full Text] [Related]
9. Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.
Mejia-Vilet JM; Gómez-Ruiz IA; Cruz C; Méndez-Pérez RA; Comunidad-Bonilla RA; Uribe-Uribe NO; Nuñez-Alvarez CA; Morales-Buenrostro LE
Clin Rheumatol; 2021 Jun; 40(6):2233-2242. PubMed ID: 33170371
[TBL] [Abstract][Full Text] [Related]
10. Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study.
Batal I; Liang K; Bastacky S; Kiss LP; McHale T; Wilson NL; Paul B; Lertratanakul A; Ahearn JM; Manzi SM; Kao AH
Lupus; 2012 Jan; 21(1):13-26. PubMed ID: 21959138
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum C4d levels in patients with systemic lupus erythematosus and its relation to lupus nephritis.
Saadati N; Miri M
Caspian J Intern Med; 2023; 14(2):231-236. PubMed ID: 37223281
[TBL] [Abstract][Full Text] [Related]
13. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
[TBL] [Abstract][Full Text] [Related]
14. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
Front Immunol; 2022; 13():885307. PubMed ID: 35720325
[TBL] [Abstract][Full Text] [Related]
15. Relation of peritubular capillary features to class of lupus nephritis.
Anutrakulchai S; Titipungul T; Pattay T; Mesung P; Puapairoj A; Sirivongs D; Pongsakul C; Futrakul P; Thinkhamrop B; Johnson RJ
BMC Nephrol; 2016 Nov; 17(1):169. PubMed ID: 27829387
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and renal survival of patients with lupus nephritis with glomerular immunoglobulin G
Jiang X; Lan L; Zhou Q; Wang H; Wang H; Chen J; Han F
Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35710146
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
[TBL] [Abstract][Full Text] [Related]
18. Analysis of clinical and laboratory characteristics and pathology of lupus nephritis-based on 710 renal biopsies in China.
Song K; Liu X; Liu J; Yin Z; Chen P; Cai G; Chen X
Clin Rheumatol; 2020 Nov; 39(11):3353-3363. PubMed ID: 32435895
[TBL] [Abstract][Full Text] [Related]
19. Urinary ferritin creatinine ratio, a potential biomarker for lupus nephritis activity.
Qi L; Xu J; Yang C; Hou X; Yang P
Clin Rheumatol; 2021 Jan; 40(1):143-149. PubMed ID: 32557256
[TBL] [Abstract][Full Text] [Related]
20. Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children.
Ghobrial EE; El Hamshary AA; Mohamed AG; Abd El Raheim YA; Talaat AA
Saudi J Kidney Dis Transpl; 2015; 26(3):507-15. PubMed ID: 26022021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
